Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection

Annals of Surgery

Volumn 239, Issue 6, 2004, Pages 859-865

  Fournier, Keith ^a   Schiller, Anne ^a   Perry, Roger R ^a   Laronga, Christine ^a   Beenken, Samuel W ^b   McGrath, Patrick C ^b   Brennan, Murray F ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Eastern Virginia Medical School ^*

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; BREAST CANCER; CANCER SURGERY; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TREATMENT INDICATION;

ADULT; AGED; AXILLA; BIOPSY, NEEDLE; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 2442683010     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000128302.05898.a7     Document Type: Conference Paper

References (25)

1. Krag D, Weaver D, Alex J, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-339.
2. Veronesi U, Paganelli G, Galimverti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet. 1997;349:1864-1867.
3. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
4. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multi-center validation study. N Engl J Med. 1998;339:941-946.
5. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275-283.
6. National Institutes of Health Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391-395.
7. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;17:368-373.
8. Cody H. Sentinel lymph node mapping in breast cancer. Breast Cancer. 1999;6:13-22.
9. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg. 2002;89:21-34.
10. Liang W, Sickle-Santanello B, Nims T. Is completion axillary dissection indicated for micrometastases in the sentinel lymph node. Am J Surg. 2001;182:365-368.
11. Sachdev U, Murphy K, Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg. 2202;183:213-217.
12. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer. J Clin Oncol. 1999;17:1720-1726.
13. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001;92:1378-1384.
14. Carter CL, Allen C, Henson DC. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
15. Hwang R, Kroshnamurthy S, Hunt K, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248-254.
16. Weiser M, Montgomery L, Tan L, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001;8:145-149.
17. Den Bakker, Weeszenberg A, de Kanter A, et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis: too early to abandon axillary clearance. J Clin Pathol. 2002;55:932-935.
18. Chu K, Turner R, Hansen N, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999;6:756-761.
19. Chu K, Turner R, Hansen N, et al. So all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg. 1999;229:536-541.
20. Ishida M, Kitamura K, Kinoshita J, et al. Detection of micrometastasis in the sentinel lymph nodes in breast cancer. Surgery. 2002;131:211-216.
21. Clare S, Sener S, Wilkens W, et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol. 1997;4:447-451.
22. de Mascarel I, Bonichon G, Coindre J, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992;66:523-527.
23. Hainsworth P, Tjandra J, Stillwell R, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 1993;80:459-463.
24. Nasser I, Lee A, Bosari S, et al. Occult axillary lymph node metastases in node-negative breast carcinoma. Hum Pathol. 1993;24:950-957.
25. Fitzgibbons P, Page D, Weaver D, et al. Prognostic factors in breast cancer: College of American Pathologists Consensus statement 1999. Arch Pathol Lab Med. 2000;124:966-978.